This device utilizes the dielectric modulation (DM) method to implement the label-free detection of breast cancer disease. In this section, we describe the results of our investigation into the DM-SC-JLTFET biosensor's performance using various settings for the TFET device's electrical characteristics. We have taken the K value of the breast cancer cell lines reported at 230 MHz in Table 3. So, the target cancer cells are made to immobilize in the cavity area of the DM-SC-JLTFET biosensor one after another, and the corresponding electrostatic parameters are recorded. When calculating the device's sensitivity, an air-filled cavity with a dielectric constant value of K = 1 is considered as the reference reading. The non-tumor breast cell (i.e., MCF10A) was also included in the analysis to show how the proposed DM-SC-JLTFET biosensor can differentiate the tumor cell into healthier breast cells.
A: Impact dielectric constant value on Energy band, Potential, and Electric field.
The shift in the energy band is the prime impact observed in the semiconductor biosensor when the target biomolecules are immobilized in the nanocavity region. The energy band shift entirely relays on the relative permittivity of the target biomolecules, and here in this proposed DM-SC-JLTFET biosensor, the absence of cancer biomolecules is represented concerning K = 1(air) or K = 4.5, which is a non-cancer-breast-cancer-cell. Figure 3(a) depicts the energy band diagram of the DM-SC-JLTFET biosensor with different biomolecules with an increased dielectric constant value. This energy band diagram is drawn for the device whose cavity is formed over the primary tunneling Junction, i.e., Fig. 1(a). The biomolecules' dielectric constant value decides the band energy twist and reduces the tunneling width between the conduction and valance band energy. Higher values of dielectric constant in biomolecules result in a greater energy-gap twist. So here, BCC T47D (K = 32) has more twists and less tunneling width for the charge carriers.
Figure 3(b) illustrates the electric field of the DM-SC-JLTFET biosensor for the given BCC immobilized in the cavity region. This device shows a high electric field near the source-channel interface due to the implemented step channel structure of the device. More charge carriers are exchanged at this primary tunneling junction concerning the increased K-values of the biomolecules. The increase in the K-value increases the interface capacitance at the oxide and semiconductor interface, and this, in turn, increases the electric Potential. Figure 3(b) shows that the higher dielectric constant valued cancer biomolecules result in higher electric filed under the cavity region of the channel.
The lateral electric field contour of the DM-SC-JLTFET biosensor is shown in Fig. 4 for all the target BCC, non-tumor cells, and air. So, the lateral electric field increases as the conjugation of the target.
biomolecules increase in the cavity region for the increment in the dielectric constant (K) value in the cavity region and the highest electric field of 1.689x106 V/cm obtained for T47D (K = 32) breast cancer biomolecule. This lateral field kept on decreasing when it moved to the drain side from the channel region, and this is because of the increased carrier exchange near the source channel junction.
The surface potential plot of the proposed device is illustrated in Fig. 3(c), where the lowest surface potential is observed for the device when the device is empty or for the non-tumor breast cell (i.e., K = 1 (air), K = 4.5 (MCF-10A)). Immobilized biomolecules' dielectric constant value is responsible for the device's resultant surface potential. The rise in the K value increases the surface potential by increasing the effective capacitance at the interface of the oxide-semiconductor region, and this device reports 1.635 V for T47D (K = 32) breast tumor cells.
The energy band at the interface of Silicon with the platinum material is depicted in Fig. 3(d), which is extracted by drawing a vertical cutline between the silicon substrate with the platinum material. The platinum material forms a non-ohmic contact and imposes the required doping profile in the silicon substrate using the work function of the platinum metal. This contact effectively influences the electron due to the available free excess electrons in the platinum material. So, this effectively improves the device’s performance. The flat band voltage decreases with an increase in the K value of the target biomolecule, so the BCC results in higher surface potential compared to non-tumor breast cells, which will help in the increment of on current of the proposed biosensor. Figure 5 illustrates the contour of surface potential in the channel region of the proposed biosensor, where the potential levels increase with the increase of the K value of target biomolecules reaching the reduced thickness of the channel region.
B: Impact dielectric constant value(K) of cancer cells on drain current (Ids & Iamb)
The drain current of the TFET device is influenced by the gate control on the channel area and the gate potential supplied. This is accomplished by adjusting the tunneling barrier length at the source-channel Junction. The source region combines Ge and Si material, which further reduces the tunneling Junction to increase the drain current. Here in the simulated DM-SC-JLTFET device, we have created the cavity area under the gate electrode of the device at both the primary and secondary tunneling junction to observe both drain current and ambipolar current. This is because the proposed step channel structure of the device effectively increases on (Ion) current and suppresses the ambipolar currents, where these two TFET devices’ currents are used for measuring the sensitivity device. The step channel structure was proposed for the device to reduce this ambipolar and leakage current, and here we made the additional cavity over the reduced thickness of the channel to immobilize the target biomolecules. First, the increase in the K value of the target BCC in the cavity region over the primary tunneling junction reduces the effective tunneling width to increase the on current of the device. This can be observed from Fig. 6 (a), where the low dielectric biomolecule and the non-tumor breast cell result in a low drain current compared to higher K-valued cancer cells.
The situation will be quite the opposite for the secondary tunneling junction, where the increased dielectric constant value increases the tunneling width to reduce the ambipolar current of the proposed device. When the K value has increased, this increases the tunneling barrier width by enlarging the flat band voltage of the device, so this help in further reduction of the ambipolar current of the proposed device. Figure 6(b) illustrates the drain current plot for the DM-SC-JLTFET device for various target biomolecules in the cavity region, which is located over the channel-drain region of the device.
Figure 7(a) give the Ion/Ioff current ratio of the proposed biosensor for all the breast cancer cell. There is a constant increment in the current ratio of the proposed DM-SC-JLTFET biosensor, and this is due to the implementation of step channel structure with the JLTFET approach, which effectively reduces the Ioff current. The Junction is not involved in device implementation, so the junction leakages are reduced, and the novel structure of the device improves the control of the gate over the channel region. This indirectly increases the on current, so the device reports a high current ratio of 5.3x107 for K = 32 (T47D) breast cancer cells. On the other side, the cavity over the secondary channel region suppresses the ambipolar current with an increase in the K value of cancer cells; Fig. 7(b) gives the Ioff/Iamb current ratio, and the device reports a high Ioff/Iamb ratio of 1.256x107 for the T47D cancer cell. The transconductance plot for the proposed device is shown in Fig. 7(c), where the device exhibits an increment in gm for a change in the dielectric constant value of the target BCC. This plot shows that the device requires less power and is suitable for low-power applications. Therefore, the proposed device shows good linearity with the change in the dielectric constant of the target biomolecules. The efficiency and performance of the device are based on reported detection sensitivity, and a suitable biosensor possesses good sensitivity. To measure the sensitivity of the simulated DM-SC-JLTFET biosensor, we use the current ratio as one of the parameters, and the following equation gives the relation to measuring the device sensitivity.
$$S(Ion/Ioff)=\frac{{I(Ion/Ioff)(bio)-I(Ion/Ioff)(air)}}{{I(Ion/Ioff)(air)}}$$
(2)
S Iamb =\(\frac{{Ion(bio)-Ion(air)}}{{Ion(air)}}\) (3)
The current ratio reported in the non-presence of the biomolecule is treated as the base for calculating the device sensitivity. So, the proposed biosensor sensitivity can be measured by using either of the drain currents, and at the same time, both give a sensitivity reading of 2.683x106 with Iamb and 9.29x102 with drain current ratio for K = 32 (T47D) breast cancer biomolecule. The corresponding sensitivity is shown in Fig. 8, and from these two sensitivity plots, we can conclude that the proposed device exhibits a high sensitivity and excellent variation for different BCC.
C: Impact dielectric constant value (K) of cancel cell on SS and threshold voltage (Vth)
For TFET-based biosensors, the essential performance parameter is subthreshold swing (SS), and this ss is related to Vgs by the following relation.
$${\text{SS}}=(\frac{{\partial {{\text{V}}_{{\text{gs}}}}}}{{\partial \log ({I_{{\text{ds}}}})}})$$
4
From the above equation, less the dependency of SS gate bias voltage and the prosed biosensor implements a step channel structure with Ge source, which keeps the tunneling width minimum to maintain a low SS value for a specific range of Vgs voltages. So, the DM-SC-JLTFET reports a decrease in SS for an increase in the K value of target biomolecules. Figure 9(a) illustrates the SS Figure for the proposed biosensor and the sensitivity, and the device reports an SS value of 32 mV/Dec for K = 32 and a sensitivity of SSS of 0.24, which is measured using the equation.
Sensitivity \({\text{S}}{{\text{S}}_{{\text{SS}}}}=\frac{{SS(air)-SS(bio)}}{{SS(air)}}\) (5)
The reduced thickness of the channel increases the overall threshold voltage of the device, and this is because the gate requires a higher voltage to align the sub-energy bands of the device. The increment in the dielectric constant of the biomolecule increases the device's threshold voltage, which is observed in the proposed device, also. The change in the threshold voltage of the device is used for calculating the sensitivity of the biosensor by using the following relation given by Eq. (6)
SVth =\(\frac{{Vth(bio)-Vth(air)}}{{Vth(air)}}\) (6)
Figure 9(b) illustrates the threshold voltage plot for the target cancer biomolecules along with the sensitivity (Svth) measured with a threshold voltage, and the proposed device shows a high sensitivity of 0.30 for K = 32 (T47D) breast cancer cells.
D: Performance comparison with the existing literature.
The performance comparison of the proposed DM-SC-JLTFET biosensor with the earlier reported works is carried out in this section. This comparative study shows how the proposed biosensor enhances the sensitivity compared to the existing biosensors. The parameters are extracted by simulating the devices for the specific target biomolecules with a similar environment condition setup. Figure 10(a) gives the drain current comparison plot between the simulated device and work reported by S. Singh et al. [20].
The proposed device reported a higher drain current compared to the work written by S. Singh et al. [20], and this is because of the structure advantage applied to the proposed biosensor. The performance of the device compared to the works reported by different researchers [42–53] and Fig. 10 (b) gives the on current comparison plot for DM-SC-JLTFET biosensor with
Table 4
Performance comparison of proposed device with literature.
|
K = 32 (T47D)
|
|
Ion (A/µm)
|
SS (mV/Dec)
|
Drain current sensitivity
|
Proposed Device
|
3.90x10− 04
|
32
|
2.3X109
|
Ref [20]
|
3.15 x10− 06
|
40
|
2.88 X108
|
Ref [14]
|
1.98X10− 06
|
-
|
106
|
Ref [21]
|
1.68X10− 5
|
35
|
2.6X107
|
the reported literature. The proposed results are extracted for the dielectric constant value for Biotin (K = 2.63). The figure shows that the proposed device exhibits superior performance compared to the earlier reported works and records higher sensitivity than the reported devices. Table IV compares the proposed biosensor's performance with various works reported. From the table, we can conclude that the proposed device shows an overall enhancement of the detection sensitivity for cancer diagnosis compared to the other reported devices. The unique novel step channel with the Junction-less structure increases the device performance in every aspect of the device's electrical characteristics and helps advance disease diagnosis. This device can be used as the universal device for diagnosing the disease at the earlier stage to implement the PoCT medical diagnosis system.